HeartCore Enterprises, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 16, 2026, reporting a significant decline in revenue and a net loss from continuing operations for both the three- and nine-month periods.
Key Highlights
- Revenue declined sharply: Revenues for the three months ended September 30, 2026 were $162,409, compared to $1,242,985 for the same period in 2025, according to the filing.
- Net loss from continuing operations: The company reported a net loss from continuing operations of $568,666 for the three months ended September 30, 2026, versus net income of $101,833 for the prior-year quarter.
- Nine-month net loss: For the nine months ended September 30, 2026, net loss attributable to HeartCore Enterprises, Inc. was $3,675,377, compared to a loss of $1,553,018 for the same period in 2025.
- Reverse stock split completed: On April 2, 2026, the company effected a 1-for-20 reverse stock split of its issued and outstanding common shares.
- Shares outstanding: As of November 16, 2026, there were 1,553,308 shares of outstanding common stock.
- Total assets decreased: Total assets were $8,143,213 as of September 30, 2026, down from $13,061,477 as of December 31, 2025.
- Accumulated deficit widened: The accumulated deficit reached $16,640,902 as of September 30, 2026, compared to $12,965,525 as of December 31, 2025.
HeartCore Enterprises Reports Q3 2026 Financial Results and Balance Sheet Changes
HeartCore Enterprises, Inc. (NASDAQ:HTCR), a Delaware-incorporated company headquartered in Tokyo, Japan, reported a steep decline in revenues for the three months ended September 30, 2026. According to the filing, revenues fell to $162,409 from $1,242,985 in the year-prior quarter. Gross profit narrowed to $16,055 for the three-month period, compared to $1,101,525 a year earlier, while the nine-month period showed a gross loss of $259,710 versus gross profit of $1,334,557 for the nine months ended September 30, 2025.
The filing disclosed that total operating expenses for the three months ended September 30, 2026 were $1,153,852, driven primarily by general and administrative expenses of $1,119,034. For the nine-month period, total operating expenses were $3,090,565. Loss from continuing operations before income tax was $592,943 for the quarter and $3,914,833 for the nine months ended September 30, 2026. The company also reported a loss from discontinued operations, net of income tax, of $27,768 for the quarter and $644,329 for the nine-month period.
On the balance sheet, total assets fell to $8,143,213 as of September 30, 2026 from $13,061,477 as of December 31, 2025, reflecting reductions in cash and cash equivalents (from $1,530,967 to $976,594), investments in marketable securities (from $3,690,187 to $1,380,553), and the absence of assets of discontinued operations that totaled $1,337,673 at year-end 2025. Total shareholders' equity attributable to HeartCore Enterprises, Inc. was $5,992,518 as of September 30, 2026, down from $9,570,132 at December 31, 2025. The filing noted that Series A convertible preferred shares outstanding decreased from 1,017 to 517 shares, with an aggregate liquidation preference of $617,916 as of September 30, 2026.
What Was Disclosed
HeartCore Enterprises filed its quarterly report covering the period ended September 30, 2026, disclosing a substantial year-over-year revenue decline, widening net losses from continuing operations, a 1-for-20 reverse stock split completed April 2, 2026, and a reduction in total assets largely tied to discontinued operations activity.




Please wait processing your request...